Insider · CIK 0001559779

Egholm Michael

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001559779

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−97.6K sh	$0.67	−$65.6K	6,137,704
2026-08-03	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−363K sh	$0.87	−$315K	6,235,331
2026-05-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−97.6K sh	$1.00	−$97.6K	6,597,956
2026-04-06	LABSTANDARD BIOTOOLS INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−197K sh	—	—	0
2026-04-06	LABSTANDARD BIOTOOLS INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+197K sh	—	—	6,790,596
2026-04-06	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−95K sh	$0.91	−$86.3K	6,695,582
2026-03-20	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to buy)A Award	Director, President & CEO	AAward	+2.35M sh	—	—	2,345,340
2026-03-20	LABSTANDARD BIOTOOLS INC.A Award	Director, President & CEO	AAward	+1.04M sh	—	—	6,594,083
2026-02-23	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−66.1K sh	$1.15	−$76K	5,551,710
2025-11-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−63.5K sh	$1.28	−$81.3K	5,617,837
2025-08-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−54.9K sh	$1.27	−$69.7K	5,681,366
2025-08-01	LABSTANDARD BIOTOOLS INC.A Award	Director, President & CEO	AAward	+3M sh	—	—	5,736,285
2025-05-28	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−9,906 sh	$1.09	−$10.8K	2,731,285
2025-05-23	LABSTANDARD BIOTOOLS INC.S Sale	Director, President & CEO	SSale	−5,473 sh	$0.94	−$5,150.093	2,741,191
2025-05-22	LABSTANDARD BIOTOOLS INC.S Sale	Director, President & CEO	SSale	−5,116 sh	$1.00	−$5,126.232	2,746,664
2025-05-21	LABSTANDARD BIOTOOLS INC.S Sale	Director, President & CEO	SSale	−4,719 sh	$1.03	−$4,860.57	2,751,780
2025-05-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−18.3K sh	$1.05	−$19.3K	2,756,499
2025-04-04	LABSTANDARD BIOTOOLS INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+197K sh	—	—	2,832,518
2025-04-04	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−57.7K sh	$1.07	−$61.7K	2,774,842
2025-04-04	LABSTANDARD BIOTOOLS INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−197K sh	—	—	196,513
2025-03-21	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to buy)A Award	Director, President & CEO	AAward	+1.78M sh	—	—	1,782,500
2025-03-21	LABSTANDARD BIOTOOLS INC.A Award	Director, President & CEO	AAward	+1.19M sh	—	—	2,636,006
2025-02-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−31K sh	$1.39	−$43.1K	1,447,673
2024-11-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−28.8K sh	$1.51	−$43.5K	1,473,704
2024-08-20	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−29.1K sh	$1.91	−$55.6K	1,502,499
2024-05-20	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+2.25M sh	—	—	2,250,000
2024-05-20	LABSTANDARD BIOTOOLS INC.A Award	Director, President & CEO	AAward	+1M sh	—	—	1,531,592
2024-04-08	LABSTANDARD BIOTOOLS INC.F Tax Payment	Director, President & CEO	FTax Payment	−103K sh	$2.71	−$278K	531,592
2024-04-05	LABSTANDARD BIOTOOLS INC.A Award	Director, President & CEO	AAward	+212K sh	—	—	634,156
2024-04-04	LABSTANDARD BIOTOOLS INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−197K sh	—	—	393,025
2024-04-04	LABSTANDARD BIOTOOLS INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+197K sh	—	—	422,030
2024-01-05	LABSTANDARD BIOTOOLS INC.A Award	Director, President & CEO	AAward	+9,006 sh	—	—	225,518
2023-04-04	LABSTANDARD BIOTOOLS INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−197K sh	—	—	589,537
2023-04-04	LABSTANDARD BIOTOOLS INC.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+197K sh	—	—	206,512
2022-06-16	IsoPlexis CorpStock OptionA Award	Director	AAward	+89K sh	—	—	89,047
2022-04-04	LABSTANDARD BIOTOOLS INC. · Restricted Stock UnitsA Award	Director, President & CEO	AAward	+786K sh	—	—	786,049
2022-04-04	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+4.53M sh	—	—	4,529,773
2015-08-31	PALL CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	President, BioPharmaceuticals	DDisposition to Issuer	−11.3K sh	—	—	0
2015-08-31	PALL CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	President, BioPharmaceuticals	DDisposition to Issuer	−9,969 sh	—	—	0
2015-08-31	PALL CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	President, BioPharmaceuticals	DDisposition to Issuer	−8,148 sh	—	—	0
2015-08-31	PALL CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	President, BioPharmaceuticals	DDisposition to Issuer	−2,408 sh	—	—	0
2015-08-31	PALL CORPEmployee Stock Option (Right to Buy)D Disposition to Issuer	President, BioPharmaceuticals	DDisposition to Issuer	−653 sh	—	—	0
2015-08-31	PALL CORPD Disposition to Issuer	President, BioPharmaceuticals	DDisposition to Issuer	−19.4K sh	$127.20	−$2.47M	0
2015-08-31	PALL CORPD Disposition to Issuer	President, BioPharmaceuticals	DDisposition to Issuer	−12.8K sh	—	—	0
2015-08-31	PALL CORPD Disposition to Issuer	President, BioPharmaceuticals	DDisposition to Issuer	−9,200.997 sh	$127.20	−$1.17M	0
2015-08-19	PALL CORPBonus UnitsA Award	President, BioPharmaceuticals	AAward	+3,258.862 sh	$126.75	+$413K	3,258.862
2015-08-13	PALL CORPA Award	President, BioPharmaceuticals	AAward	+17.1K sh	$126.67	+$2.16M	18,005.997
2015-08-13	PALL CORPF Tax Payment	President, BioPharmaceuticals	FTax Payment	−8,805 sh	$126.67	−$1.12M	9,200.997
2015-07-15	PALL CORPRestricted Stock UnitsM Exercise/Conversion	President, BioPharmaceuticals	MExercise/Conversion	−1,595.333 sh	—	—	0
2015-07-15	PALL CORPM Exercise/Conversion	President, BioPharmaceuticals	MExercise/Conversion	+1,595.333 sh	$125.52	+$200K	1,595.997

Recent filings

Accepted (ET)
Aug 244
Egholm Michael0001193125-26-363758
SEC(opens sec.gov)
Aug 44
Egholm Michael0001193125-26-333225
SEC(opens sec.gov)
May 224
Egholm Michael0001193125-26-237181
SEC(opens sec.gov)
Apr 84
Egholm Michael0001193125-26-148615
SEC(opens sec.gov)
Feb 244
Egholm Michael0001193125-26-067641
SEC(opens sec.gov)
Nov 244
Egholm Michael0001193125-25-293843
SEC(opens sec.gov)
Aug 224
Egholm Michael0000950170-25-111052
SEC(opens sec.gov)
Aug 54
Egholm Michael0000950170-25-103296
SEC(opens sec.gov)
May 304
Egholm Michael0000950170-25-079886
SEC(opens sec.gov)
May 284
Egholm Michael0000950170-25-078457
SEC(opens sec.gov)
May 274
Egholm Michael0000950170-25-078043
SEC(opens sec.gov)
May 224
Egholm Michael0000950170-25-076591
SEC(opens sec.gov)
Apr 84
Egholm Michael0000950170-25-052047
SEC(opens sec.gov)

Companies

Address

C/O STANDARD BIOTOOLS INC. 50 MILK STREET, 10TH FLOOR

BOSTON, MA, 02109